The Cystic Fibrosis Foundation joined patient and health groups in writing a letter to House appropriators, asking they ensure the National Institute of Allergy and Infectious Diseases receives boosted funding needed to meet its critical, multi-faceted mission.
Site Search
The Cystic Fibrosis Foundation joined the Partnership to Protect Coverage in strongly urging governors and states to take additional action to protect Medicaid coverage for the children and families over the next year.
In a letter to the U.S. Department of Health and Human Services and the U.S. Department of Labor, the Foundation requested the two agencies provide guidance to health insurers across all plan types clarifying that they must follow the co-pay assistance provision included in the 2020 Notice of Benefit and Payment Parameters.
In a letter to the California Department of Health Care Services, the Cystic Fibrosis Foundation expressed support for California's proposal to provide multi-year continuous Medicaid coverage for children under age four, which would protect patients and families from gaps in care and promote health equity.
In a letter to all Utah legislators, the Cystic Fibrosis Foundation expressed its support for SB 152, which would require insurers to apply third-party assistance to out-of-pocket maximums and other patient cost-sharing requirements.
In a letter to the Insurance Subcommittee of South Carolina's House Labor, Commerce, and Industry Committee, the Foundation expressed its support for H.3618 which would require insurers to apply third-party assistance to out-of-pocket maximums and other patient cost-sharing requirements, as well as ban maximizer programs and alternative programs
In a letter to the Ohio House Insurance Committee, the Cystic Fibrosis Foundation expressed its support of HB 130 to streamline prior authorization requirements and urged the committee to lower the gold carding threshold for prescribers.
In a letter to Vermont's Senate Committee on Health and Welfare, the Cystic Fibrosis Foundation provided feedback on S 98 which would give the Green Mountain Care Board the ability to cap the purchase price of certain drugs with the goal to improve access to and affordability of care for Vermonters.
In a letter to Missouri's House Committee on Health and Mental Health Policy, the Cystic Fibrosis Foundation expressed its support for HB 1628, which would require insurers to apply third-party assistance to out-of-pocket maximums and other patient cost-sharing requirements.
In a letter to Maryland's Senate Finance Committee and House Health and Government Operations Committee, the Cystic Fibrosis Foundation expressed its support for HB 879/SB 595, which would require insurers to apply third-party assistance to out-of-pocket maximums and other patient cost-sharing requirements as well as ban alternative funding prog